Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
3
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cystic fibrosis
deals
duchenne muscular dystrophy
spark therapeutics
vertex pharmaceuticals
10x genomics
abbvie
acute myeloid leukemia
allergan
What
bio
drugs
3
×
fda
roundup
3
×
news
ahead
aren’t
asco
august
biotech
branded
busy
choices
commissioner
consumers
costly
counterweight
days
decisions
developers
devices
drug
elevatebio
gene
generic
graft
help
imminent
legacy
long
medicare
medications
moves
nods
noteworthy
opioid
past
patients
prices
regulatory
Language
unset
Current search:
roundup
×
drugs
×
" sarepta therapeutics "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More